Whereas PD-1/PD-L1 axis-mediated immune suppression is commonly attributed to PD-1 signaling, PD-L1 is known to mediate intracellular signaling that promotes cancer progression, immune escape, and metabolic reprogramming (218). Here, CD274 is linked to cancer.